AR037211A1 - Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1 - Google Patents

Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1

Info

Publication number
AR037211A1
AR037211A1 ARP020104215A ARP020104215A AR037211A1 AR 037211 A1 AR037211 A1 AR 037211A1 AR P020104215 A ARP020104215 A AR P020104215A AR P020104215 A ARP020104215 A AR P020104215A AR 037211 A1 AR037211 A1 AR 037211A1
Authority
AR
Argentina
Prior art keywords
alkyl
heteroarilo
orl
derivatives
independently selected
Prior art date
Application number
ARP020104215A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR037211A1 publication Critical patent/AR037211A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Reivindicación 1: Un compuesto representado por la fórmula (1) o las sales farmacéuticamente aceptables del mismo, en el cual R es R4-heteroarilo o fórmula (2); R1 es H ó alquilo C1-6; R2 y R3 son independientemente seleccionados entre el grupo que consiste en -CH3, -OCH3, flúor, cloro, bromo y yodo; R4 representa 1 a 4 sustituyentes independientemente seleccionados entre el grupo que consiste en H, halo, alquilo C1-6, -CN, -CF3, -OCF3, -(CH2)n-OR5-; -(CH2)n-NR5R6, -(CH2)n-NHSO2R5, -(CH2)n-NH(CH2)2NR5R6, -(CH2)n-NHC(O)NR5R7, -(CH2)n-NH(CH2)2OR5 t 1-piperazinilo; n es 0, 1 ó 3; R5 y R6 son independientemente seleccionados entre el grupo que consiste en H y alquilo C1-3 y R7 es H, alquilo C1-3 o aminoalquilo C1-3; ó una sal o solvato farmacéuticamente aceptable de los mismos, composiciones farmacéuticas elaborados con los mismos y el uso de dichos compuestos en el tratamiento del dolor, ansiedad, la tos, el asma, la depresión y el alcoholismo.
ARP020104215A 2001-11-07 2002-11-05 Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1 AR037211A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33328401P 2001-11-07 2001-11-07

Publications (1)

Publication Number Publication Date
AR037211A1 true AR037211A1 (es) 2004-10-27

Family

ID=23302135

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020104215A AR037211A1 (es) 2001-11-07 2002-11-05 Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1

Country Status (27)

Country Link
US (1) US6727254B2 (es)
EP (1) EP1442036B1 (es)
JP (2) JP4246066B2 (es)
KR (1) KR100596261B1 (es)
CN (1) CN1252068C (es)
AR (1) AR037211A1 (es)
AT (1) ATE315566T1 (es)
BR (1) BR0213907A (es)
CA (1) CA2465871C (es)
CY (1) CY1105208T1 (es)
DE (1) DE60208724T2 (es)
DK (1) DK1442036T3 (es)
EC (1) ECSP045096A (es)
ES (1) ES2256590T3 (es)
HK (1) HK1063019A1 (es)
HU (1) HUP0402329A2 (es)
IL (2) IL161120A0 (es)
MX (1) MXPA04004276A (es)
MY (1) MY126268A (es)
NO (1) NO329026B1 (es)
NZ (1) NZ532088A (es)
PE (1) PE20030719A1 (es)
PL (1) PL370269A1 (es)
RU (1) RU2327698C2 (es)
TW (1) TWI317360B (es)
WO (1) WO2003039469A2 (es)
ZA (1) ZA200403404B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
US20040067950A1 (en) * 1998-07-27 2004-04-08 Schering-Plough Corporation High affinity ligands for nociceptin receptor ORL-1
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
ATE443699T1 (de) * 2002-12-06 2009-10-15 Purdue Research Foundation Pyridine zur behandlung von verletztemsäugetiernervengewebe
WO2005089761A1 (en) * 2004-03-17 2005-09-29 Pfizer Limited Combination for treating inflammatory diseases
EP1791838A2 (en) * 2004-09-15 2007-06-06 Schering-Plough Ltd. Process for preparing substituted 8-azabicyclo[3.2.1] octan-3-ols
DE102005016460A1 (de) * 2005-04-11 2006-10-19 Grünenthal GmbH Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
PE20071159A1 (es) * 2005-10-31 2007-11-30 Schering Corp Derivados de tropano 3-monosustituido como ligandos de receptores de nociceptina
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
WO2010010458A1 (en) * 2008-07-21 2010-01-28 Purdue Pharma L.P. Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
GB201004311D0 (en) 2010-03-15 2010-04-28 Proximagen Ltd New enzyme inhibitor compounds
GB201115853D0 (en) 2011-09-14 2011-10-26 Proximagen Ltd New enzyme inhibitor compounds
US9724340B2 (en) * 2015-07-31 2017-08-08 Attenua, Inc. Antitussive compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352707A (en) 1992-03-26 1994-10-04 Harbor Branch Oceanographic Institution, Inc. Method for treating airway congestion
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
TW590268U (en) * 2000-08-08 2004-06-01 Wistron Corp Heat dissipating device

Also Published As

Publication number Publication date
RU2004117542A (ru) 2006-01-10
PL370269A1 (en) 2005-05-16
TW200301765A (en) 2003-07-16
CA2465871A1 (en) 2003-05-15
CN1252068C (zh) 2006-04-19
DE60208724D1 (de) 2006-04-06
ATE315566T1 (de) 2006-02-15
NZ532088A (en) 2006-05-26
WO2003039469A3 (en) 2003-10-16
HK1063019A1 (en) 2004-12-10
ES2256590T3 (es) 2006-07-16
EP1442036A2 (en) 2004-08-04
US20030119847A1 (en) 2003-06-26
JP2005508367A (ja) 2005-03-31
MXPA04004276A (es) 2004-08-11
KR20050043725A (ko) 2005-05-11
CY1105208T1 (el) 2010-03-03
BR0213907A (pt) 2004-09-28
CN1582288A (zh) 2005-02-16
DE60208724T2 (de) 2006-11-02
JP4246066B2 (ja) 2009-04-02
KR100596261B1 (ko) 2006-06-30
TWI317360B (en) 2009-11-21
NO20042294L (no) 2004-07-15
HUP0402329A2 (hu) 2005-02-28
CA2465871C (en) 2009-01-20
IL161120A (en) 2010-11-30
MY126268A (en) 2006-09-29
DK1442036T3 (da) 2006-05-15
ECSP045096A (es) 2004-06-28
IL161120A0 (en) 2004-08-31
EP1442036B1 (en) 2006-01-11
RU2327698C2 (ru) 2008-06-27
US6727254B2 (en) 2004-04-27
NO329026B1 (no) 2010-08-02
WO2003039469A2 (en) 2003-05-15
JP2009035556A (ja) 2009-02-19
ZA200403404B (en) 2005-08-15
PE20030719A1 (es) 2003-08-28

Similar Documents

Publication Publication Date Title
AR037211A1 (es) Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1
HRP20110957T1 (hr) Derivati kinolina kao inhibitori fosfodiesteraza
ECSP034475A (es) Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1
AR041260A1 (es) Piperazinas sustituidas por heterociclos para el tratamiento de la esquizofrenia
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
RU2363700C2 (ru) Производные хинуклидина и фармацевтические композиции, содержащие их
AR040406A1 (es) Antagonistas de histamina h3 de benzimidazolona
AR046711A1 (es) 5-7-diaminopirazolo[4,3d]pirimidinas como inhibidores de la pde-5,composiciones farmaceuticas que las contienen y usos en el tratamiento de hipertensiones
PE20030762A1 (es) Compuestos heterociclicos como antagonistas nk1
AR040405A1 (es) Derivados de bencimidazol utiles como antagonistas de histamina h3
AR068413A2 (es) Derivados 8-amino, metodos de preparacion, composiciones farmaceuticas y su uso en terapia
ME00555A (en) Tryasolyl tropane derivatives as ccr5 modulators
PE20030761A1 (es) Derivados del 7-amino-benzotiazol
CO5611139A2 (es) Pirimidinas aril sustituidas y el uso de las mismas
AR037534A1 (es) Derivado de adamantano, su uso en la fabricacion de un medicamento para usar en terapia, composicion farmaceutica, proceso para la preparacion de dicho compuesto y dicha composicion y compuestos intermediarios
DE602006006850D1 (de) Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate
HRP20070529T3 (en) Imidazole derivatives as glutmate receptor antagonists
AR034009A1 (es) Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos
AR056613A1 (es) Compuestos derivados de lapachona, su preparacion y metodos de uso de los mismos para el tratamiento o prevencion de trastornos proliferativos celulares y composiciones farmaceuticas que los contienen
EA200300718A1 (ru) Производные 3-индолина, которые могут применяться при лечении психиатрических и неврологических расстройств
CO2020001326A2 (es) Nuevos compuestos heterocíclicos como inhibidores de cdk8/19
AR041246A1 (es) Derivados de piridina; un procedimiento de preparacion de los mismos y composicion farmaceutica que los contiene
CO5660263A2 (es) Derivados de imidazol heteroaril sustituidos como antagonistas del receptor de glutamato
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
AR072802A1 (es) Derivados piperidinicos de esteres de acido bifenil-2-il-carbamico, antagonistas de receptores muscarinicos m3, composiciones farmaceuticas que los contienen y usos de los mismos para el tratamiento de trastornos digestivos,respiratorios y/o urinarios.

Legal Events

Date Code Title Description
FB Suspension of granting procedure